These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 29179268

  • 1. [Natural changes of high-risk HPV in women with negative for intraepithelial lesion or malignancy: a prospective 1 year study].
    He Y, Wu YM, Yin CH, Geng YN, Yang SL, Kang LD.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):740-744. PubMed ID: 29179268
    [Abstract] [Full Text] [Related]

  • 2. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
    Wang R, Li X, Qian M, Niu J, You Z.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar 25; 50(3):210-5. PubMed ID: 26268412
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness of Different Testing Strategies Applied for Cervical Cancer Screening in Shuangliu District, Chengdu City].
    Zeng X, Li J, Kang LN, Yan LP, He Z, Liao GD, Xi MR, Chen MY.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep 25; 53(5):896-903. PubMed ID: 36224694
    [Abstract] [Full Text] [Related]

  • 4. Yield and mode of diagnosis of cervical intraepithelial neoplasia 3 or cancer among women with negative cervical cytology and positive high-risk human papillomavirus test results.
    Pretorius RG, Belinson JL, Peterson P, Azizi F, Lo A.
    J Low Genit Tract Dis; 2013 Oct 25; 17(4):430-9. PubMed ID: 23595040
    [Abstract] [Full Text] [Related]

  • 5. Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.
    Feng T, Cheng B, Sun W, Yang Y.
    BMC Womens Health; 2023 Nov 14; 23(1):599. PubMed ID: 37957634
    [Abstract] [Full Text] [Related]

  • 6. Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
    Tracht JM, Davis AD, Fasciano DN, Eltoum IA.
    Cancer Cytopathol; 2017 Oct 14; 125(10):795-805. PubMed ID: 28817235
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov 23; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr 23; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 11. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.
    Pretorius RG, Peterson P, Azizi F, Burchette RJ.
    Am J Obstet Gynecol; 2006 Nov 23; 195(5):1260-5. PubMed ID: 17074547
    [Abstract] [Full Text] [Related]

  • 12. The use of colposcopy for triage in HPV-positive women aged 65 years and older.
    Kuenkel E, Jaeger A, Bohlmann I, Bergauer F, Kuehler-Obbarius C, Prieske K, Maass-Poppenhusen K, Schmalfeldt B, Woelber L.
    Arch Gynecol Obstet; 2024 Apr 23; 309(4):1561-1567. PubMed ID: 38081959
    [Abstract] [Full Text] [Related]

  • 13. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 14. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan 25; 41(1):34-7. PubMed ID: 16635326
    [Abstract] [Full Text] [Related]

  • 15. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
    Wang JL, Yang YZ, Dong WW, Sun J, Tao HT, Li RX, Hu Y.
    Asian Pac J Cancer Prev; 2013 Jan 25; 14(5):2979-82. PubMed ID: 23803065
    [Abstract] [Full Text] [Related]

  • 16. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
    Gu L, Hong Z, Gao H, Qiu L, Di W.
    Cytopathology; 2019 Jul 25; 30(4):419-425. PubMed ID: 31069857
    [Abstract] [Full Text] [Related]

  • 17. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.
    BJOG; 2006 Nov 25; 113(11):1303-7. PubMed ID: 16978225
    [Abstract] [Full Text] [Related]

  • 18. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
    Gold MA, Thomas MA, Huh WK, Sarto GE, Day SP.
    J Low Genit Tract Dis; 2013 Jan 25; 17(1):51-7. PubMed ID: 22885641
    [Abstract] [Full Text] [Related]

  • 19. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.
    Coll Antropol; 2010 Mar 25; 34(1):19-24. PubMed ID: 20432728
    [Abstract] [Full Text] [Related]

  • 20. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
    Bekkers RL, Hanselaar AG, Melchers WJ, van Schaik JH, Boonstra H, Massuger LF.
    Ned Tijdschr Geneeskd; 2003 Feb 15; 147(7):302-6. PubMed ID: 12622008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.